IL-9 antibody (PE)

Catalog No. ABIN2663808

The PE-conjugated Mouse Monoclonal anti-IL-9 antibody (Clone MH9A4) (ABIN2663808) specifically detects IL-9 in FACS. The antibody is reactive with Human samples.

Quick Overview for IL-9 antibody (PE) (ABIN2663808)

Target: IL-9 (IL9) (Interleukin 9 (IL9))

Reactivity: Human

Host: Mouse

Clonality: Monoclonal

Conjugate: This IL-9 antibody is conjugated to PE

Application: Flow Cytometry (FACS)

Clone: MH9A4

Product Details anti-IL-9 Antibody (PE)

Purification: The antibody was purified by affinity chromatography, and conjugated with PE under optimal conditions. The solution is free of unconjugated PE and unconjugated antibody.

Isotype: IgG2b kappa

Application Details

Application Notes: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Handling

Concentration: 0.2 mg/mL

Preservative: Sodium azide

Precaution of Use: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Handling Advice: Protect from prolonged exposure to light. Do not freeze.

Storage: 4 °C

Storage Comment: The antibody solution should be stored undiluted between 2°C and 8°C.

Target Details for IL-9

Target: IL-9 (IL9) (Interleukin 9 (IL9))

Alternative Name: IL-9

Background: IL-9 is a potent, T cell-derived, T cell growth factor which can also enhance mast cell activity and IL-3- or IL-4- dependent proliferation of bone marrow-derived mast cells. IL-9 synergizes with erythropoietin to promote erythroid colony formation. IL-9 has also been reported to protect human T cells from apoptosis induced by IL-2 withdrawal. IL-9 is upregulated in human eosinophils by TNF-α and IL1-β. IL-9 has been reported to downregulate the oxidative burst in activated human alveolar macrophages and induce TGF-β production. The recently characterized Th-9 helper cell lineage is characterized by the production of IL-9. The MH9A4 antibody reacts with human IL-9. The MH9A4 antibody can neutralize the bioactivity of natural or recombinant IL-9.

Pathways: JAK-STAT Signaling